AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,566 Increased By 157.7 (2.13%)
BR30 24,786 Increased By 749.4 (3.12%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)
World

Biden poised to name EPA chief, to get COVID-19 vaccine in public to build support

  • The expected nomination of Michael Regan, according to three sources with knowledge of the discussions.
  • Biden's focus on confronting climate change marks a sharp change from the four years of President Donald Trump's administration.
Published December 18, 2020

WILMINGTON: President-elect Joe Biden plans to nominate North Carolina's top environmental regulator to head the US Environmental Protection Agency, sources said, the latest in a slate of nominees who will be central to a sweeping plan to fight climate change.

The expected nomination of Michael Regan, according to three sources with knowledge of the discussions, follows appointments to head the departments of Energy, Transportation and the Interior, as well as a new office leading domestic climate policy coordination at the White House.

On their shoulders will be Biden's goal of moving the United States to net-zero greenhouse gas emissions by 2050 - a once-unimaginable task that will require the world's second-largest emitter to overhaul major parts of its economy, from cars, trucks and planes to power plants, farms and buildings.

Biden's focus on confronting climate change marks a sharp change from the four years of President Donald Trump's administration, which saw the United States exit the Paris climate accord and the federal government work to soften or dismantle climate regulations, saying they would hinder the economy.

The sources, who asked not to be named discussing the matter, told Reuters that Regan was in the final stages of vetting by the Biden team. If confirmed, he would be the first Black man to run the EPA, adding to a historically diverse administration.

Biden, who is set to take office on Jan. 20, has also vowed to make the fight against the coronavirus that has killed more than 307,000 Americans his top priority when he takes office.

He will be contending with the logistical challenges of a mass inoculation as well as overcoming some skepticism about the vaccine's efficacy and safety among the general public.

A vaccine made by Pfizer Inc and German partner BioNTech SE is expected to become widely available next year.

Biden will publicly get the vaccine next week, according to transition officials. At age 78, Biden is in the high-risk group for COVID-19, which has proven particularly dangerous among the elderly.

Vice President Mike Pence, who has headed the White House coronavirus task force, will receive the vaccine in public on Friday, the highest-profile recipient to date.

Trump will get the vaccine when his medical team decides it is best, according to the White House.

Trump, who frequently downplayed the severity of the pandemic and feuded with top US public health officials, was hospitalized in October after testing positive for COVID-19.

SECOND VACCINE

All over the United States, doctors, nurses and delivery people are wrestling with challenges in the vaccine rollout including delays, anxiety and keeping the vaccine at just the right level of cold.

A panel of outside advisers to the US Food and Drug Administration is expected to endorse emergency use of a second vaccine by Moderna Inc in a meeting on Thursday.

Many Americans remain skeptical. Only 61% of respondents in a Reuters/Ipsos poll, conducted from Dec. 2 to 8, said they were open to getting vaccinated.

That is short of the 70% level that public health officials have said is needed to reach herd immunity - achieved when a large portion of a given population is immune to a disease - either through exposure or vaccination. Roughly 5% of Americans are believed to have been infected by the novel coronavirus. One of those tasked by Biden with building support for the vaccination campaign, Dr. Marcella Nunez-Smith, told a Black civil rights group on Wednesday that the science was sound.

"The political interference risk was really, really removed," Nunez-Smith said on a call with the National Association for the Advancement of Colored People.

Comments

Comments are closed.